David Roberts
David Roberts is a co-founder of Mara Labs with a background in public health and biomedical engineering. He discusses the company’s work on sulforaphane formulations and how it chooses ingredients for its products.
Statements
12 statements
David Roberts says not every broccoli seed contains glucoraphanin, the precursor he discusses for sulforaphane.
David Roberts discusses why a glucoraphanin supplement may deliver a different amount of sulforaphane from one containing sulforaphane directly. The precursor has to be converted, and human studies show that active myrosinase affects the amount produced.
David Roberts says curcumin crosses the gut barrier poorly. He claims phytosomal or liposomal forms improve uptake by about threefold, which he considers insufficient.
David Roberts describes research he says used his company's sulforaphane formulation.
David Roberts describes a hypothesis in which sulforaphane affects the release of material from lysosomes.
David Roberts talks about glutathione when explaining why he rates sulforaphane highly.
David Roberts distinguishes the precursor glucoraphanin from active sulforaphane and gives his view of their effects on NRF2.
David Roberts recounts comparing six substances using cells from a patient in the lab.
David Roberts describes the sulforaphane yield he attributes to seeds sold by his company.
David Roberts says his company added a watercress compound called PEITC and claims it increases the activity of a pathway the product targets with sulforaphane.
David Roberts claims berberine performed better than diazepam on a sleep measure in research he describes.
David Roberts describes what he recalls happening after a washout period in the broccoli-sprout study under discussion.
